Annual Non Current Assets
$595.00 K
-$910.00 K-60.47%
31 March 2024
Summary:
Immunovant annual long term assets is currently $595.00 thousand, with the most recent change of -$910.00 thousand (-60.47%) on 31 March 2024. During the last 3 years, it has fallen by -$2.89 million (-82.92%). IMVT annual non current assets is now -82.92% below its all-time high of $3.48 million, reached on 31 March 2021.IMVT Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$8.34 M
+$7.70 M+1220.92%
30 September 2024
Summary:
Immunovant quarterly long term assets is currently $8.34 million, with the most recent change of +$7.70 million (+1220.92%) on 30 September 2024. Over the past year, it has increased by +$7.44 million (+833.37%). IMVT quarterly non current assets is now -92.82% below its all-time high of $116.02 million, reached on 30 September 2019.IMVT Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.5% | +833.4% |
| 3 y3 years | -82.9% | +183.5% |
| 5 y5 years | +643.8% | -92.8% |
IMVT Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.9% | at low | at high | +1300.8% |
| 5 y | 5 years | -82.9% | +643.8% | -92.8% | >+9999.0% |
| alltime | all time | -82.9% | +643.8% | -92.8% | >+9999.0% |
Immunovant Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.34 M(+1220.9%) |
| June 2024 | - | $631.00 K(+6.1%) |
| Mar 2024 | $665.77 M(+64.7%) | $595.00 K(-11.2%) |
| Dec 2023 | - | $670.00 K(-25.0%) |
| Sept 2023 | - | $893.00 K(-26.0%) |
| June 2023 | - | $1.21 M(-19.8%) |
| Mar 2023 | $404.33 M(-21.2%) | $1.50 M(-17.4%) |
| Dec 2022 | - | $1.82 M(-11.4%) |
| Sept 2022 | - | $2.06 M(-12.6%) |
| June 2022 | - | $2.35 M(-10.7%) |
| Mar 2022 | $512.93 M | $2.63 M(-2.6%) |
| Dec 2021 | - | $2.70 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $2.94 M(-8.2%) |
| June 2021 | - | $3.20 M(-8.1%) |
| Mar 2021 | $409.01 M(+275.0%) | $3.48 M(-3.3%) |
| Dec 2020 | - | $3.60 M(-0.8%) |
| Sept 2020 | - | $3.63 M(-13.1%) |
| June 2020 | - | $4.17 M(+1242.4%) |
| Mar 2020 | $109.08 M(>+9900.0%) | $311.00 K(+534.7%) |
| Dec 2019 | - | $49.00 K(-100.0%) |
| Sept 2019 | - | $116.02 M(+0.6%) |
| June 2019 | - | $115.34 M(>+9900.0%) |
| Mar 2019 | - | $176.70 K |
| Dec 2018 | $325.00 K | - |
FAQ
- What is Immunovant annual long term assets?
- What is the all time high annual non current assets for Immunovant?
- What is Immunovant annual non current assets year-on-year change?
- What is Immunovant quarterly long term assets?
- What is the all time high quarterly non current assets for Immunovant?
- What is Immunovant quarterly non current assets year-on-year change?
What is Immunovant annual long term assets?
The current annual non current assets of IMVT is $595.00 K
What is the all time high annual non current assets for Immunovant?
Immunovant all-time high annual long term assets is $3.48 M
What is Immunovant annual non current assets year-on-year change?
Over the past year, IMVT annual long term assets has changed by -$910.00 K (-60.47%)
What is Immunovant quarterly long term assets?
The current quarterly non current assets of IMVT is $8.34 M
What is the all time high quarterly non current assets for Immunovant?
Immunovant all-time high quarterly long term assets is $116.02 M
What is Immunovant quarterly non current assets year-on-year change?
Over the past year, IMVT quarterly long term assets has changed by +$7.44 M (+833.37%)